HYPERSENSITIVITY OF HUMAN BREAST CANCER CELLS TO TRIPTOLIDE IN CONJUNCTION WITH HSP90 INHIBITORS AND RADIATION EXPOSURE

被引:0
|
作者
Kudryavtsev, V. [1 ]
Kabakov, A. [1 ]
机构
[1] Med Radiol Res Ctr, Dept Radiat Biochem, Obninsk, Russia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:55 / 55
页数:1
相关论文
共 50 条
  • [21] HSP90 INHIBITOR GELDANAMYCIN AS A RADIATION RESPONSE MODIFICATOR IN HUMAN BLOOD CELLS
    Stankova, Katia
    Savova, Gergana
    Nikolov, Vladimir
    Boteva, Rayna
    DOSE-RESPONSE, 2015, 13 (01): : 1 - 11
  • [22] Combination of Hsp90 inhibitors and MEK inhibitors abrogates ERK activation in pancreatic cancer cells
    Zhang, Tao
    Li, Yanyan
    Sun, Duxin
    CANCER RESEARCH, 2009, 69
  • [23] Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors
    Moita, Ana J. Rodrigues
    Bandolik, Jan J.
    Hansen, Finn K.
    Kurz, Thomas
    Hamacher, Alexandra
    Kassack, Matthias U.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 22
  • [24] Plant-Based HSP90 Inhibitors in Breast Cancer Models: A Systematic Review
    Zarguan, Ilham
    Ghoul, Sonia
    Belayachi, Lamiae
    Benjouad, Abdelaziz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)
  • [25] Hsp90: an emerging target for breast cancer therapy
    Beliakoff, J
    Whitesell, L
    ANTI-CANCER DRUGS, 2004, 15 (07) : 651 - 662
  • [26] Hsp90 inhibition with 17AAG can sensitize human breast cancer cells to taxol
    Kudryavtsev, V.
    Makarova, Y.
    Kabakov, A.
    EJC SUPPLEMENTS, 2010, 8 (03): : 86 - 86
  • [27] TARGETING HSP90 CHAPERONE ACTIVITY IN HUMAN BREAST CANCER CELLS CAN SENSITIZE THEM TO RADIOTHERAPY
    Kudryavtsev, V.
    Demidkina, A.
    Mosina, V.
    Kabakov, A.
    BREAST, 2013, 22 : S95 - S95
  • [28] Expression of hsp90 and cyclin D1 in human breast cancer
    Yano, M
    Naito, Z
    Yokoyama, M
    Shiraki, Y
    Ishiwata, T
    Inokuchi, M
    Asano, G
    CANCER LETTERS, 1999, 137 (01) : 45 - 51
  • [29] Tethered Hsp90 inhibitors carrying optical or radioiodinated probes reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells.
    Barrott, Jared J.
    Smith, Aaron P.
    Osada, Takuya
    Ramanujam, Nimmi
    Zalutsky, Michael R.
    Lyerly, Kim
    Haystead, Timothy A. J.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [30] HSP90 inhibition in HER2-positive breast cancer cells
    Qadir, Z.
    Crown, J.
    Jensen, M. R.
    Clynes, M.
    Slamon, D.
    O'Donovan, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)